w
r
dowdl
seroepidemiolog
survey
coronaviru
strain
infect
popul
children
j
epidemiol
indirect
hemagglutin
iha
test
coronaviru
antibodi
use
serodiagnost
seroepidemiolog
studi
popul
children
subject
rang
age
year
live
home
particip
longitudin
surveil
respiratori
ill
period
respiratori
ill
observ
associ
serorespons
fourfold
greater
antibodi
rise
addit
serorespons
associ
unreport
subclin
ill
frequenc
infect
cyclic
coronaviru
oc
infect
peak
differ
year
among
popul
serorespons
occur
mainli
fall
winter
spring
quarter
preexist
antibodi
demonstr
onethird
children
serorespons
clinic
studi
indic
frequent
complaint
infect
sore
throat
coryza
cough
frequent
find
pharyng
inject
coryza
fever
serolog
studi
coronaviru
oc
work
adult
hendley
et
al
found
per
cent
cold
serolog
relat
infect
figur
increas
per
cent
winter
spring
season
consid
surveil
infect
young
adult
hamr
beem
found
per
cent
infect
occur
three
season
high
preval
per
cent
interven
season
low
preval
infect
also
occur
winter
spring
season
pattern
similar
infect
rate
season
distribut
demonstr
adult
popul
confirm
extens
studi
includ
group
children
limit
assay
procedur
antibodi
entir
satisfactori
complement
fixat
cf
test
use
serodiagnosi
recommend
serosurvey
sinc
cf
antibodi
rel
shortliv
neutral
antibodi
persist
longer
examin
larg
number
sera
neutral
nt
test
cell
cultur
tediou
earlier
report
describ
develop
indirect
hemagglutin
iha
test
antibodi
test
shown
sensit
seroepidemiolog
survey
specif
result
close
parallel
obtain
nt
test
report
describ
applic
iha
test
seroepidemiolog
studi
role
infect
occur
children
popul
period
number
season
distribut
ill
infect
antibodi
preval
relat
antibodi
protect
clinic
syndrom
studi
studi
popul
longitudin
survey
respiratori
ill
conduct
churchsponsor
children
home
atlanta
area
popul
describ
detail
previou
studi
year
total
number
children
median
age
percentag
turnov
number
percentag
children
origin
studi
group
shown
tabl
collect
specimen
children
symptom
respiratori
ill
sent
housemoth
home
clinic
examin
attend
physician
record
sign
symptom
standard
form
acut
convalesc
blood
specimen
collect
week
apart
control
sera
collect
children
three
time
year
first
year
studi
least
twice
yearli
collect
made
succeed
year
viru
coronaviru
strain
origin
isol
human
embryon
kidney
cell
cultur
passag
cell
use
studi
antigen
product
prepar
antigen
iha
test
describ
detail
elsewher
briefli
cell
diploid
human
fetal
lung
fibroblast
grown
bottl
eagl
minimum
essenti
medium
mem
contain
per
cent
fetal
calf
serum
aureomycin
ml
c
monolay
complet
twowash
cycl
perform
serumfre
eagl
mem
reduc
calf
serum
protein
cell
inocul
ml
serumfre
eagl
mem
ad
incub
continu
minim
cytopath
effect
detect
ml
medium
decant
cell
frozen
c
bottl
frozen
thaw
three
time
content
centrifug
lightli
supernat
fluid
collect
store
c
antisera
product
immun
sera
prepar
new
zealand
white
rabbit
subcutan
inocul
partial
pu
sera
previous
test
cf
andor
hemagglutin
inhibit
diagnost
rise
antibodi
titer
influenza
b
parainfluenza
type
adenoviru
mump
viru
respiratori
syncyti
viru
herpesviru
mycoplasma
pneumonia
coronaviru
oc
studi
sera
test
iha
antibodi
coronaviru
cf
test
perform
frequenc
serum
anticomplementari
activ
probabl
relat
length
storag
previou
usag
iha
test
previous
describ
test
perform
microtit
u
plate
ml
volum
dilut
normal
hors
serum
phosphatebuff
salin
ph
use
diluent
test
serum
titrat
volum
twofold
dilut
begin
dilut
control
consist
first
four
dilut
serum
plu
tannic
acidtr
unsensit
erythrocyt
sensit
erythrocyt
plu
diluent
rabbit
antiserum
plate
shaken
permit
stand
hour
room
temperatur
erythrocyteset
pattern
read
fourfold
greater
increas
antibodi
titer
consid
indic
infect
sera
inactiv
c
min
incid
respiratori
ill
serorespons
coronaviru
period
respiratori
ill
report
iha
serorespons
demonstr
none
ill
could
relat
isol
andor
serorespons
respiratori
diseas
agent
includ
previou
studi
addit
serorespons
detect
fourfold
greater
increas
antibodi
titer
control
bleed
total
number
serorespons
tabl
total
record
year
septemb
decemb
thirtyon
associ
report
ill
remaind
repres
either
unreport
diseas
subclin
infect
fiftysix
serorespons
found
throughout
year
studi
occur
among
children
report
respiratori
ill
includ
serorespons
individu
two
serorespons
surveil
period
season
distribut
one
hundr
ten
serorespons
occur
three
outbreak
fall
winter
spring
quarter
year
septemb
decemb
figur
fortyeight
sero
respons
found
fallwinterspr
quarter
year
previous
mention
serorespons
found
summer
quarter
entir
studi
children
report
ill
serorespons
could
associ
ill
account
per
cent
total
ill
seen
fall
quarter
per
cent
winter
spring
quarter
per
cent
summer
quarter
although
largest
number
serorespons
occur
three
outbreak
mention
percentag
year
worth
note
strain
account
per
cent
total
respiratori
ill
winter
quarter
evid
preexist
antibodi
person
serorespons
popul
per
cent
preexist
antibodi
titer
greater
two
consecut
serum
specimen
collect
rise
antibodi
titer
tabl
preexist
antibodi
less
frequent
younger
age
group
older
age
group
almost
third
group
highest
number
serorespons
preexist
antibodi
thirteen
children
serorespons
preexist
antibodi
titer
greater
clinic
syndrom
clinic
histori
avail
children
report
respiratori
ill
tabl
major
present
complaint
sore
throat
per
cent
coryza
per
cent
cough
per
cent
fever
per
cent
predomin
physic
find
pharyng
inject
per
cent
coryza
per
cent
fever
c
per
cent
fever
c
per
cent
cervic
aden
per
cent
statist
signific
differ
found
fourfold
greater
rise
iha
titer
pair
acut
convalesc
sera
two
consecut
serum
specimen
prior
serorespons
x
children
parenthes
clinic
aspect
respiratori
ill
children
without
preexist
antibodi
discuss
develop
iha
test
enabl
us
conduct
seroepidemiolog
studi
popul
previous
investig
hemagglutin
inhibit
techniqu
evid
coronaviru
oc
infect
iha
antibodi
serorespons
coronaviru
account
per
cent
respiratori
ill
report
twentynin
report
ill
found
three
distinct
outbreak
occur
fall
winter
spring
quarter
year
fall
winter
anoth
serorespons
found
children
asymptomat
report
ill
period
studi
unlik
previou
studi
larg
number
serorespons
found
fall
quarter
fall
year
exampl
diagnost
antibodi
rise
detect
per
cent
report
ill
natur
outbreak
cyclic
close
resembl
oc
outbreak
oc
found
previou
studi
year
major
outbreak
occur
year
low
number
serorespons
also
found
period
high
oc
preval
observ
other
well
studi
combin
total
per
cent
oc
per
cent
infect
account
per
cent
ill
report
period
higher
per
cent
found
hendley
et
al
compar
length
time
howev
found
oc
account
per
cent
respiratori
ill
season
spring
winter
exclud
compar
age
popul
studi
could
also
account
differ
find
preval
iha
antibodi
total
popul
stay
rel
constant
period
previou
studi
demonstr
persist
nt
antibodi
close
relationship
note
iha
nt
antibodi
anim
coronavirus
despit
presenc
antibodi
two
infect
occur
individu
studi
reinfect
coronavirus
also
note
previou
studi
previou
studi
experiment
natur
infect
human
anim
coronavirus
reveal
heterolog
antibodi
respons
earlier
studi
antibodi
oc
human
sera
simultan
serorespons
found
among
pair
sera
diagnost
antibodi
rise
either
viru
despit
fact
per
cent
pair
preexist
antibodi
viru
hendley
et
al
also
report
antibodi
increas
either
two
coronavirus
accompani
increas
antibodi
observ
appli
oc
heterotyp
antibodi
rise
caus
unknown
uncharacter
strain
exclud
find
well
investig
must
interpret
caution
particularli
view
absenc
isol
etiolog
agent
respons
tht
ill
lack
compar
serolog
method
assay
oc
antibodi
present
knowledg
serolog
interrelationship
possibl
human
anim
coronavirus
previou
clinic
studi
report
kapikian
et
al
chief
complaint
patient
shed
viru
coryza
nasal
congest
follow
sneez
sore
throat
headach
cough
muscular
ach
chill
fever
order
hendley
et
al
found
ill
due
adult
character
mainli
nasal
symptom
littl
fever
also
found
ill
due
oc
resembl
cold
caus
rhinovirus
character
pharyng
cough
nasal
congest
find
base
patient
serorespons
indic
close
parallel
regard
nasal
involv
attend
physician
saw
fever
describ
hendley
et
al
although
frequenc
fever
less
describ
previou
studi
oc
presenc
preexist
antibodi
seem
signific
amelior
effect
respiratori
ill
caus
